James Gregory
Associate Director Arvinas, Inc.
Seminars
Wednesday 29th October 2025
Developing a Portfolio of CNS-penetrant Degraders
2:00 pm
Download the Full Event Guide for Full Session Details.
- Progress in orally bioavailable, CNS-penetrant PROTAC degraders
- Update on ARV-102 central target and pathway engagement
- Exploring new PROTAC approaches to neurological diseases
